The short answer
Cranberry findings with warfarin differ by preparation and study. One small volunteer trial found a stronger INR response, while a trial of daily cranberry juice in stable warfarin patients found no consistent clinically important effect. These results do not establish that every cranberry product causes bleeding, nor that concentrated supplements are interchangeable with juice.
What this answer covers
Oral Vaccinium macrocarpon beverages or supplements with oral warfarin, with quantity and preparation identified. Other Vaccinium species and mixed products are not included automatically.
- Supplement or preparation
- Cranberry
- Medication ingredient
- warfarin
What does the evidence show?
In a 12-person crossover experiment, a cranberry preparation increased the area under the INR-time curve after a single warfarin dose by approximately 30%, without altering measured warfarin concentrations. A separate randomized trial of 30 stable warfarin patients used 240 mL cranberry juice daily for two weeks. It found no concentration difference and an INR difference at just one time point, which the authors considered unlikely to be clinically important. Neither study was designed to establish a precise long-term hemorrhage rate.
Which forms and conditions matter?
Juice volume, extract concentration, serving size and other ingredients matter. The juice trial cannot clear a concentrated capsule or large change in daily intake. Conversely, a result from a selected preparation does not establish the same effect for ordinary servings of another product. The distinction between increased INR response and an actual bleeding event should remain clear.
What should I discuss with my care team?
Discuss a cranberry supplement or a substantial intake change with the anticoagulation service. Provide the amount and formulation rather than only the name cranberry. The clinician can decide whether INR follow-up is needed. The inspected studies provide no reliable dose-spacing rule or instructions to adjust warfarin independently.
How certain is the answer?
The small trials involved different exposures and populations, and the results conflict. A percentage change in INR-time area in healthy volunteers is not a percentage increase in an individual's chance of bleeding. The article therefore preserves formulation limits and uncertainty instead of converting a mechanistic or laboratory endpoint into a universal harm claim.
Evidence and practical considerations
Side effects & toxicity
Cranberry findings with warfarin differ by preparation and study. One small volunteer trial found a stronger INR response, while a trial of daily cranberry juice in stable warfarin patients found no consistent clinically important effect. These results do not establish that every cranberry product causes bleeding, nor that concentrated supplements are interchangeable with juice.
- Exact scope
- Oral Vaccinium macrocarpon beverages or supplements with oral warfarin, with quantity and preparation identified. Other Vaccinium species and mixed products are not included automatically. with Oral warfarin, including warfarin sodium tablets with the warfarin active moiety.
- Medication form and route
- oral warfarin
- Timing or duration
- Study-specific durations are described in each source exposure; no universally safe exposure duration has been established.
What remains uncertain
- The small trials involved different exposures and populations, and the results conflict. A percentage change in INR-time area in healthy volunteers is not a percentage increase in an individual's chance of bleeding. The article therefore preserves formulation limits and uncertainty instead of converting a mechanistic or laboratory endpoint into a universal harm claim.
Factors that may matter: Exact supplement preparation and other ingredients; Starting, stopping or changing supplement intake; Baseline anticoagulation control and clinician-supervised monitoring.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral warfarin sodium tablets.
The label advises closer INR monitoring when botanicals are started or stopped, identifies variable botanical composition and lists selected potential interactions. Vitamin K intake should remain consistent.
How this applies: Oral warfarin sodium has warfarin as its active moiety. Label-level botanical and vitamin K monitoring advice applies; it is not proof of this exact supplement effect. Oral Vaccinium macrocarpon beverages or supplements with oral warfarin, with quantity and preparation identified. Other Vaccinium species and mixed products are not included automatically.
Regulatory precautions do not quantify the incidence for every exact preparation or prove an interaction for an unlisted ingredient. Warfarin sodium is bridged to the warfarin active moiety only for the oral product.
Source 2: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 healthy men in an open-label randomized crossover study.
Cranberry increased the INR-time area by about 30% without changing warfarin concentrations; garlic did not significantly change pharmacokinetic or pharmacodynamic measures.
How this applies: Use only the cranberry or garlic arm for its corresponding exact botanical. Findings for cranberry are not transferred to garlic or vice versa. Exact package scope: Oral Vaccinium macrocarpon beverages or supplements with oral warfarin, with quantity and preparation identified. Other Vaccinium species and mixed products are not included automatically.
Small single-dose volunteer study, not a bleeding-outcome trial; preparation-specific doses require publisher full-text confirmation and are not generalized here.
Source 3: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 30 patients on stable warfarin with starting INR 1.7 to 3.3.
Warfarin concentrations did not differ. INR differed on one measurement day only; the authors considered this isolated change unlikely to be clinically important.
How this applies: Direct Vaccinium macrocarpon juice plus stable warfarin study. Capsule, extract and high-volume beverage exposures are not assumed equivalent. Exact package scope: Oral Vaccinium macrocarpon beverages or supplements with oral warfarin, with quantity and preparation identified. Other Vaccinium species and mixed products are not included automatically.
Small short trial of one beverage amount; findings do not cover concentrated extracts, very large quantities or illness-related changes in diet.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and contradictory findings assessed for this exact pair. Article drafted and existing statements adjudicated. Clinical sign-off has not been recorded. | |
| Research summary published |
Article revision: c7b66965ea7bbb80
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.